Clinical Trial 1434

New York, NY 10021


Study Summary:

SPRI Clinical Trials is conducting a research study for people with depression. This is a multicenter, double-blind, randomized, parallel-group, placebo-controlled Phase III study on the efficacy and safety of Quetiapine Fumarate Sustained-release (SEROQUEL®) as monotherapy in the treatment of patients with major depressive disorder.


Qualified Participants Must:

• Be between 18-65 years of age
• Be feeling down and depressed
• Have lost interest in your normal activities
• Have lost your appetite
• Have difficulty sleeping


Qualified Participants May Receive:

If you qualify, you may be eligible to participate in a study testing the effectiveness of an investigational drug for the treatment of depression at no cost. simple hit counter


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.